According to MarketWatch, The FDA approved the Alzheimer's drug Legembi from Eisai and Biogen A quick look at the daily charts for $BIIB shows that it's already trading on or above major moving averages (ie. 9,21,50 SMA's). Also, seeing as this is a nice, green day for the SPY and BIIB has been beaten down recently, it's a nice long option for medium term traders...
In downtrend, bounced back to Supply zone Current Monthly chart price range 73 - 217 Earning 7/26/2022 Estimate 4.09 Short 200 Stop 220 Target 140 Risk management is much more important than a good entry point. I am not a PRO trader. In my trading plan, the Max Risk of each short term trade should be less than 1% of an account.
Order SELL BIIB NASDAQ.NMS Stop 278.12 LMT 278.12 will be automatically canceled at 20230401 01:00:00 EST BIIB daily bearish hammer end of wave 5 expect correction at the very least
The PEAD projected a Neutral outlook for $BIIB after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 75%.
Order SELL BIIB NASDAQ.NMS Stop 249.27 LMT 249.27 will be automatically canceled at 20230401 01:00:00 EST BIIB daily bearish hammer
The PEAD projected a Bearish outlook for $BIIB after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
Journal Entry Bias: Positive. Sentiment: Optimistic. Emoji (emotion): Speculative 🧙♂️. Null Hypothesis: Buy. Alternative Hypothesis: Sell, Buy then Sell. Signals: ... Position: Day/Swing trade. Notes: I'm anticipating the market to buy the earnings surprise 07/20/22 BMO: www.estimize.com Barron's Company Overview: www.barrons.com . Other:...
Looking at the options chain today, i would buy the $255 calls with 2022-9-16 expiration date for about $3.40 premium. Looking forward to read your opinion about it.
possible long for biib, in a long term buy zone now with it breaking over descending resistance after a double bottom
My recent post was a bearish view for BIIB, it included some Fibonacci Circles and I am questioning my ability to plot these. So I have posted a much simpler chart that shows a dominant trend line in green that should be maintained Once the descending channel reaches this level price should move upwards. Here is the bear view
Remains a very risky trade. A falling wedge pattern might be developing. The break usually occurs to the upside. Above 190.00 supports a bullish trend direction. Crossing below this level will negate the positive stance. Further bullish support for a price action above 197.50. Consolidation is between 193.75 and 201.25. Crossing above 201.25 might target...
The PEAD projected a Bullish outlook for $BIIB after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 87.5%.
Repeating structure in green rectangle Continuing the up channel Red horizontals are the very similar points just on different magnitudes
Coiling and looks to be painting a 5 wave C here. About to tap 200 MONTH MA and a lifetime .618 retrace to end wave II to start a potentially massive wave III. Will potentially trade all the way down to 140s but am going to start nibbling here for a lifetime HODL.
BIIB Continuation LONG. TPs and SL on the chart. Max leverage.
We're getting close the descending wedge and we're touching multi-year support at around 205. $BIIB has been in a downtrend since June with no signs of life so we could see a bounce or breakdown to lower lows.
The basics: Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. I expect this industry to continue to grow as new advancements are made. Trade Idea: Since September of 2013 Biogen...